StatStrip Glucose Hospital Meter System. Model/Catalog Number: 63685. Prescription use blood gluc...
FDA Device Recall #Z-0681-2025 — Class I — November 20, 2024
Recall Summary
| Recall Number | Z-0681-2025 |
| Classification | Class I — Serious risk |
| Date Initiated | November 20, 2024 |
| Status | Ongoing |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Nova Biomedical Corporation |
| Location | Waltham, MA |
| Product Type | Devices |
| Quantity | 2,365 units |
Product Description
StatStrip Glucose Hospital Meter System. Model/Catalog Number: 63685. Prescription use blood glucose meter for near-patient testing.
Reason for Recall
A software bug within the Gen 2 StatStrip Hospital Meter firmware leads to transmission of erroneous glucose patient test results to a healthcare institution's data management system (DMS) at healthcare sites using WiFi if a user navigates to the Review Results screen while the meter is in the process of transmitting the current glucose test result to the DMS. The risk of this software defect is erroneously high or low glucose results being documented in a patient's medical record, which may lead to incorrect treatment.
Distribution Pattern
Distribution US Nationwide including Puerto Rico, Germany, Italy, Israel, Switzerland, Australia, Great Britain, and the Netherlands.
Lot / Code Information
Model No 63685. UDI-DI (01)10385480636858. Software Versions: v0.0.13.10 to v0.0.13.44
Other Recalls from Nova Biomedical Corporation
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-0682-2025 | Class I | StatStrip Glucose Ketone Hospital Meter System.... | Nov 20, 2024 |
| Z-0683-2025 | Class I | StatStrip Glucose Ketone (mmol/L) Hospital Mete... | Nov 20, 2024 |
| Z-0208-2024 | Class II | Nova Stat Profile Prime Plus POC Analyzer (CE)-... | Sep 18, 2023 |
| Z-0207-2024 | Class II | Nova Biomedical Prime Plus Analyzer -Intended t... | Sep 18, 2023 |
| Z-2732-2017 | Class II | Nova Biomedical Stat Profile Prime Analyzer as ... | Jun 19, 2017 |
Frequently Asked Questions
A software recall means the device's embedded software or firmware has a defect that could affect its performance or safety. Many software recalls are corrected through firmware updates that can be applied without physically replacing the device. For implantable devices, the update may be delivered wirelessly during a routine clinic visit. For external devices, the manufacturer may provide updated software files or replacement units. Contact your healthcare provider to determine whether your specific device and software version are affected and what action is recommended.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.